Use of Thiol Compounds to Treat Neurological Disease
The present disclosure relates, in general, to use of small diffusible thiols in the treatment of neurodegenerative diseases associated with glutamate excitotoxicity, protein aggregation and oxidative stress in the central nervous system, particularly in the brain.
Saved in:
Main Authors | , |
---|---|
Format | Patent |
Language | English |
Published |
13.04.2023
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | The present disclosure relates, in general, to use of small diffusible thiols in the treatment of neurodegenerative diseases associated with glutamate excitotoxicity, protein aggregation and oxidative stress in the central nervous system, particularly in the brain. |
---|---|
Bibliography: | Application Number: US202217711572 |